Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients
Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients have?
Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients has 106 citations in the OpenAlex counts ScholarIQ stores.
When was Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients published?
Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients has 2017 year in the ScholarIQ index.
What is the open-access status of Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients?
Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients has closed oa status in the ScholarIQ index.
What is the DOI of Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients?
The DOI for Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients is on the source record.
What is the PMID of Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients?
The PMID for Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients is on the source record.
What is the OpenAlex record for Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients?
The OpenAlex for Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients is on the source record.